New diagnostic tests for vector-borne diseases (HERA)
Funds late-stage development of new diagnostic tests for vector-borne diseases such as those spread by mosquitoes and ticks.
This is a single-stage EU4Health Project Grant, one of four topics sharing the same HERA Action Grants 2025 call and 4 December 2025 deadline. This topic carries an indicative budget of EUR 10,000,000, the second largest of the four topics, which range from EUR 1,000,000 to EUR 18,000,000. The objective specifically calls out rapid tests as a priority within the broader diagnostic toolkit, alongsi…
This topic funds late-stage development of diagnostic tests for vector-borne diseases (VBDs), aiming to bring devices to near-market readiness, improve existing tests' accessibility, affordability or accuracy, or create new solutions where none exist. It wants proposals that build on molecular assays and serological tests backed by evidence on novel antigens or genetic sequences, including clinical testing, and that stay clear of duplicating ongoing EU-funded work such as Horizon Europe projects.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Find grantsGovernment Grants for Startups: What Deeptech Founders Should Know
A practical guide to government grants for startups, including Grants.gov, SBIR/STTR, state programs, eligibility, fit, timelines, and when to apply.
More from HaDEA
All grants from this funder →AI and Health-Data Flagship for Cardiovascular and Related Disease Care
🇪🇺HaDEA · European Union
Funds a flagship project that federates EU health data and pilots AI tools for cardiovascular risk prediction, prevention and personalised care.
Cancer screening programmes for gastric cancer
🇪🇺HaDEA · European Union
Funds a stepwise rollout of gastric cancer screening programmes across EU Member States, including AI-assisted screening.
Coordinated access to European spaceports
🇪🇺HaDEA · European Union
Funds a study that proposes common rules and best practices so European launch providers can access any European spaceport more easily.
Digital enablers and building blocks for autonomous space transportation systems
🇪🇺HaDEA · European Union
Funds early-stage digital technology — health monitoring, smart avionics, AI data processing — that makes future launch systems more autonomous.
Digital solutions for space transportation autonomy — targeting demonstration
🇪🇺HaDEA · European Union
Funds on-ground or in-orbit demonstration of structural-damage detection and thermo-mechanical monitoring for reusable launch systems.
EU4Health Conferences and Events Grants
🇪🇺HaDEA · European Union
Funds not-for-profit, Union-wide conferences on EU health priorities that bring together policymakers, scientists and civil society.
Similar grants
Browse the directory →
AI Predictive Biomarkers for Chronic Diseases
🇪🇺European Commission · European Union
Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.
Challenge Programme — AMR Diagnostics for LRTI
🇩🇰NNF · Denmark
Supports diagnostic innovations for antimicrobial resistant respiratory infections in Danish consortia.
Innovative healthcare interventions for non-communicable diseases
🇪🇺European Commission · European Union
Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
Portable and versatile Point-of-care diagnostics
🇪🇺European Commission · European Union
Funds €5–7M projects that make point-of-care diagnostics more portable, versatile, accurate and useful in clinical practice.
Horizon Health: Antibody Therapies for Emerging Viruses
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.